Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
Left Ventricular Strain Quantification From 4D Echocardiography
2 other identifiers
observational
1
1 country
1
Brief Summary
Magnetic resonance imaging (MRI) and echocardiography are two imaging methods that are used to obtain pictures of the heart and assess heart function. This study will evaluate a new, four-dimensional echocardiography approach of obtaining heart images to determine if it is as effective at evaluating heart function as MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2008
CompletedFirst Posted
Study publicly available on registry
April 18, 2008
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMarch 30, 2020
June 1, 2016
2.9 years
April 16, 2008
March 27, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Establish baseline strain patterns for future studies evaluating alterations in left ventricular strain/strain rates associated with regional myocardial ischemia and injury
Measured at participants' study visit
Study Arms (2)
1
Healthy volunteers will be recruited through the use of an approved study recruitment flyer.
2
Chemotherapy patients will be approached at the time of their nuclear scan to rule out cardiac disease prior to chemotherapy. These patients will be referred to the study by their doctor for the assessment of heart function.
Eligibility Criteria
Participants will consist of two groups: 1. Normal volunteers will be recruited through the use of an approved study recruitment flyer. 2. Chemotherapy patients will be approached at the time of their nuclear scan to rule out cardiac disease prior to chemotherapy. These patients will be referred to the study by their doctor for the assessment of heart function.
You may qualify if:
- No evidence of underlying cardiac disease based on history or electrocardiogram (ECG)
- Adequate intravenous access in one arm
You may not qualify if:
- Pregnant or breastfeeding; if pre-menopausal, not practicing acceptable method of birth control
- History of any other medical condition that is likely to hinder study conduct or pose a safety concern, in the opinion of the investigator
- History of cardiac disease, including heart attack or heart valve disease
- Uncontrolled high blood pressure, defined as systolic blood pressure higher than 160 mm Hg and/or diastolic pressure higher than 100 mm Hg
- Abnormal ECG or chest pain syndrome
- Claustrophobia
- Resting heart rate greater than 110 bpm
- Unable to undergo MRI procedure (e.g., pacemaker, metallic implants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Yale University/Magnetic Resonance Research Center (MR-TAC)/Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Related Publications (7)
Constable RT, Rath KM, Sinusas AJ, Gore JC. Development and evaluation of tracking algorithms for cardiac wall motion analysis using phase velocity MR imaging. Magn Reson Med. 1994 Jul;32(1):33-42. doi: 10.1002/mrm.1910320106.
PMID: 8084235BACKGROUNDDuncan J, Shi P, Constable T, Sinusas A. Physical and geometrical modeling for image-based recovery of left ventricular deformation. Prog Biophys Mol Biol. 1998;69(2-3):333-51. doi: 10.1016/s0079-6107(98)00014-5.
PMID: 9785945BACKGROUNDShi P, Sinusas AJ, Constable RT, Ritman E, Duncan JS. Point-tracked quantitative analysis of left ventricular surface motion from 3-D image sequences. IEEE Trans Med Imaging. 2000 Jan;19(1):36-50. doi: 10.1109/42.832958.
PMID: 10782617BACKGROUNDPapademetris X, Sinusas AJ, Dione DP, Duncan JS. Estimation of 3D left ventricular deformation from echocardiography. Med Image Anal. 2001 Mar;5(1):17-28. doi: 10.1016/s1361-8415(00)00022-0.
PMID: 11231174BACKGROUNDSinusas AJ, Papademetris X, Constable RT, Dione DP, Slade MD, Shi P, Duncan JS. Quantification of 3-D regional myocardial deformation: shape-based analysis of magnetic resonance images. Am J Physiol Heart Circ Physiol. 2001 Aug;281(2):H698-714. doi: 10.1152/ajpheart.2001.281.2.H698.
PMID: 11454574BACKGROUNDMeyer FG, Constable RT, Sinusas AJ, Duncan JS. Tracking myocardial deformation using phase contrast MR velocity fields: a stochastic approach. IEEE Trans Med Imaging. 1996;15(4):453-65. doi: 10.1109/42.511749.
PMID: 18215927BACKGROUNDShi P, Sinusas AJ, Constable RT, Duncan JS. Volumetric deformation analysis using mechanics-based data fusion: Applications in cardiac motion recovery. International J Computer Vision 35:87-107, 1999
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Albert J. Sinusas, MD
Yale University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2008
First Posted
April 18, 2008
Study Start
July 1, 2010
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
March 30, 2020
Record last verified: 2016-06